期刊文献+

肺结核并发糖尿病患者经强化治疗后痰菌阳性的相关因素分析 被引量:3

Correlative factors analysis on sputum positive patients with pulmonary tuberculosis complicated with diabetes mellitus after intensive treatment
下载PDF
导出
摘要 目的探讨肺结核并发糖尿病患者经强化抗结核治疗后痰菌阳性的相关因素,为临床干预提供理论依据。方法 239例肺结核并发糖尿病患者均接受抗结核治疗,在强化治疗结束后根据痰菌检测结果分为痰菌阳性组(n=82)与痰菌阴性组(n=157);采用单因素分析、非条件logistic回归分析进行相关因素分析。结果单因素分析发现2组患者糖尿病病程、治疗前空腹血糖水平、治疗前血清白蛋白水平、强化治疗末期空腹血糖水平、肺结核病灶范围、肺结核空洞数目等比较差异有统计学意义(P<0.05)。非条件logistic回归分析发现糖尿病病程、治疗前空腹血糖水平、肺结核病灶范围是痰菌阳性的独立危险因素(P<0.05),而治疗前血清白蛋白水平是痰菌阳性的独立保护因素(P<0.05)。结论糖尿病病程、治疗前空腹血糖水平、肺结核病灶范围是肺结核并发糖尿病患者经强化抗结核治疗后痰菌阳性的独立危险因素,而治疗前血清白蛋白水平是其独立的保护因素。 Objective To investigate the correlative factors of sputum positive patients with pulmonary tuberculosis complicated with diabetes mellitus after intensive treatment,and to provide theoretical basis for clinical intervention.Methods Two hundred and thirty-nine patients with pulmonary tuberculosis complicated with diabetes mellitus were treated with anti-tuberculosis treatment,then according to the results of sputum detection after intensive treatment,the patients were divided into positive group(n=82) and negative group(n=157).The correlative factors were analyzed by univariate analysis and unconditional Logistic regression analysis.Results The univariate analysis showed that there were statistically significant differences in the course of diabetes,fasting plasma glucose and serum albumin levels before treatment,fasting plasma glucose level in the final stage of intensive treatment,lesions range of pulmonary tuberculosis,number of pulmonary tuberculosis cavity between the two groups(P0.05).The logistic regression analysis showed that the course of diabetes,fasting plasma glucose level before treatment and lesions range of pulmonary tuberculosis were independent risk factors of positive sputum examination(P0.05),while the serum albumin level before treatment was an independent protective factor(P0.05).Conclusion The course of diabetes,fasting plasma glucose level before treatment and lesions range of pulmonary tuberculosis are independent risk factors of sputum positive patients with pulmonary tuberculosis complicated with diabetes mellitus after intensive treatment,and the serum albumin level before treatment is an independent protective factor.
作者 陈玲
出处 《新乡医学院学报》 CAS 2012年第12期942-944,共3页 Journal of Xinxiang Medical University
关键词 肺结核 糖尿病 痰菌阳性 相关因素 pulmonary tuberculosis diabetes mellitus positive sputum correlative factor
  • 相关文献

参考文献8

  • 1Mamaev I A,Musaeva A M, Abusuev S A,et al. The epidemiologi-cal features of concomitance of diabetes mellitus and pulmonary tu-berculosis [ J]. Probl Tuberk Bolezn ,2008 (5 ) :23-25.
  • 2Patel A K, Rami K C, Ghanchi F D. Radiological presentation of patients of pulmonary tuberculosis with diabetes mellitus[ J]. Lung India,2011,28( 1 ) :70.
  • 3肺结核诊断和治疗指南[J].中华结核和呼吸杂志,2001,24(2):70-74. 被引量:2863
  • 4屈春梅.地特胰岛素联合二甲双胍治疗2型糖尿病疗效观察[J].新乡医学院学报,2011,28(4):465-466. 被引量:9
  • 5Zhang Q, Xiao H, Sugawara I. Tuberculosis complicated by diabetes mellitus at Shanghai pulmonary hospital, China [ J ]. Jpn J Infect Dis, 2009,62 ( 5 ) : 390 -391.
  • 6P6rez-Nav.uro L M,Fuentes-Domnguez F,Morales-Romero J,ei al.Factors associated to pulmonary tuberculosis in patients with diabe-tes mellitus from Veracruz,Mexico [ J]. Gac Med Mex ,2011,147(3):219-225.
  • 7陈建,李宁秀.我国肺结核病耐药状况的Meta分析[J].新乡医学院学报,2006,23(4):370-372. 被引量:11
  • 8Srikanth P,Kamesh S,Daley P. Bleach optimization of sputum smearmicroscopy for pulmonary tuberculosis[ J]. Indian J Tuberc ,2009,56(4) :174-184.

二级参考文献38

  • 1张立兴.中国结核病控制工作面临的挑战[J].中华流行病学杂志,2004,25(8):645-646. 被引量:42
  • 2范素莲,卫风谦,郭磊,高炳田,江振英,高建彬,李伟.初治肺结核212例耐药性测定[J].中国防痨杂志,1995,17(3):128-129. 被引量:15
  • 3Hermansen K, Davies M, Derezinski T. A 26-week randomized, parallel,treat-to-target trial comparing insulin detmnir with NPH insulin as add-on therapy to oral glucose-lowering druge in insulin- naive people with type 2 diabetes [ J ]. Diabetes Care, 2006,29 (6) :1269-1274.
  • 4Rosenstock J, Davies M, Home P D. A randomized,52-week, treat- to-target trial comparing insulin detemir with insulin glargine when administered as add-on to glucose-lowering drugs in insulin-naive people with type 2 diabetes [ J ]. Diabetologia, 2008,51 ( 3 ) : 408- 416.
  • 5Hordem S V,Wright J E, Umpteby A M. Comparison of the effects on glucose and lipid metabolism of equipotent doses of insulin det- emir and NPH insulin with a 16-h euglycaemic clamp[J]. Diabeto- logia ,2005,48 ( 3 ) :420-426.
  • 6Klein O. Albumin-bound basal insulin analogues ( insulin detemir and NN344) : comparable time-action profile but less variability than insulin glargine in type 2 diabetes[J].Diabetes Obes Metab, 2007,9 ( 3 ) :290-299.
  • 7Heise T. Lower within-subject variability of insulin detemir in com- parison to NPH insulin and insulin glargine in people with type 1 diabetes[J]. Diabetes ,2004,53 ( 6 ) : 1614-1620.
  • 8Bohm A ,Staiger H, Hennige A M. Effect of insulin detemir, cornpared on hunmn insulin, on 3T3-L, adipogenesis [ J ]. Regul tYpt, 2008,151(1/3) :160-163.
  • 9Domhorst A,Ltiddeke H J, Koenen C. Transferring to insulin det- emir from NPt4 insulin or irtsulin glargine in type 2 diabetes pa- tients on basal-only therapy with oral atttidiabetic drugs improves glycaemic control and reduces weight gain and risk of hypoglycae- mia : 14-week follow-up data from PREDICTIVE[J].Diabetes Obes Metab ,2008,10( 1 ) :75-81.
  • 10中国2型糖尿病防治指南(2007年版)[J].中华医学杂志,2008,88(18):1227-1245. 被引量:954

共引文献2880

同被引文献14

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部